SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No. 2)
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): FEBRUARY 7, 2003
MEDICOR LTD.
(Exact Name of Registrant as Specified in its Charter)
DELAWARE
(State or other Jurisdiction of Incorporation)
333-64420 14-1871462
(Commission File No.) (IRS Employer identification No.)
4560 S. Decatur Blvd., Ste. 300
Las Vegas, Nevada 89103
(Address of principal executive offices and Zip Code)
Registrant's telephone number, including area code: (702) 932-4560
Scientio, Inc.
P.O. Box 94007
Belle Harbor, NY 11694-0007
(Former name and address)
This Form 8-K/A is being filed to amend the Form 8-K filed by MediCor Ltd., a
Delaware corporation formerly known as Scientio, Inc., on February 24, 2003 to
update and supplement Item 4 thereof reflecting the retention of MediCor's
certifying accountant and the termination of the Registrant's former certifying
accountant resulting from the merger accounted for as a reverse acquisition as
reported in the Form 8-K.
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
As previously reported in this Current Report on Form 8-K, pursuant to the
merger effected under the merger agreement dated as of February 7, 2003,
MediCor, with its board's approval, re-engaged Greenberg & Company LLC as
MediCor's independent accountants following the merger. Deloitte & Touche LLP
audited the financial statements of International Integrated Incorporated prior
to the merger. The merger was accounted for as a reverse acquisition. Deloitte &
Touche LLP is not providing audit services to MediCor or International
Integrated Incorporated following the merger and the auditor-client relationship
between the entities and Deloitte & Touche LLP formally ceased on May 29, 2003,
following Deloitte & Touche's issuance of its report on International Integrated
Incorporated's financial statements contained in Amendment No. 1 to this Current
Report on Form 8-K. Deloitte & Touche's report on the financial statements for
neither of the prior two fiscal years contained an adverse opinion or disclaimer
of opinion or was modified as to uncertainty, audit scope, or accounting
principles. There were no disagreements with Deloitte & Touche on any matter of
accounting principles or practices, financial statement disclosure or auditing
scope or procedure.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA STATEMENTS AND EXHIBITS
(c) Exhibits.
Exhibit Number Description
-------------- -----------
Exhibit 16.1 Letter from Deloitte & Touche LLP
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: July 7, 2003
MEDICOR LTD.,
a Delaware corporation
By: /s/ Jim J. McGhan
_________________________
Jim J. McGhan
Chief Operating Officer
EXHIBIT INDEX
EXHIBIT DESCRIPTION
NUMBER -----------
- ------
Exhibit 16.1 Letter from Deloitte & Touche LLP